Company Filing History:
Years Active: 2018-2020
Title: The Innovations of Leonidas C. Platanias
Introduction
Leonidas C. Platanias is a notable inventor based in Glencoe, IL (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
Platanias's latest patents focus on substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2). These compounds exhibit kinase inhibition activity, specifically targeting Mnk1 and Mnk2 kinases. The disclosed compounds may be utilized in pharmaceutical compositions and methods for treating diseases associated with Mnk1 and Mnk2 kinase activity, including cancers, diabetes, autism, and fragile X syndrome.
Career Highlights
Leonidas C. Platanias is affiliated with Northwestern University, where he continues to advance research in his field. His work has garnered attention for its innovative approach to addressing complex medical conditions through targeted therapies.
Collaborations
Some of his notable coworkers include Gary E. Schiltz and Rama K. Mishra, who have collaborated with him on various research projects.
Conclusion
Leonidas C. Platanias is a distinguished inventor whose work in kinase inhibitors holds promise for the future of medical treatments. His contributions to pharmaceutical sciences are paving the way for new therapeutic options.